Negotiation News

At The Gap Partnership we recognise the importance of staying relevant in challenging conditions. We constantly monitor on-line resources, newspapers, magazines and business journals for articles which highlight the impact of negotiation on business strategy.

Bausch + Lomb to acquire ISTA for $500m

Bausch + Lomb is to spend approximately $500 million on ISTA Pharmaceuticals.

27 March 2012

Eye health company Bausch + Lomb is to purchase ISTA Pharmaceuticals in a deal worth approximately $500 million (£313 million).

The transaction, which is expected to be concluded during the second quarter of the year, will see Bausch + Lomb expand its presence in the eyecare industry by making use of ISTA's portfolio of anti-inflammatory allergy, glaucoma and spreading agents.

ISTA may have made use of merger and acquisition advisers during negotiations with Bausch + Lomb and president and chief executive officer of ISTA Vincente Anido Jr said the transaction has been finalised after "a thorough process that delivers shareholders an important return on their investment".

His counterpart at Bausch + Lomb Brent Saunders described ISTA - which recorded net revenues of $45.1 million in the fourth quarter of 200 - as "an excellent strategic fit".

The deal is "an important step in Bausch + Lomb's commitment to becoming the best global eye health company", he added.

Source: Bausch + Lomb press release, March 26th

Posted by Ken Hayes